EC REVIEW OF THE ATMP REGULATION – CELL THERAPY CATAPULT RESPONSES 1 Introduction It is clear from the very small number of MAA approved to date that the registration process for ATMPs is complex and not easily satisfi - Small Cells - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-04-19 09:57:25 Biology Biotechnology Stem cells Induced stem cells Cell biology Pharmaceutical industry Cell therapy European Directorate for the Quality of Medicines Induced pluripotent stem cell Therapy Biopharmaceutical Quality control in tissue engineering		EC REVIEW OF THE ATMP REGULATION – CELL THERAPY CATAPULT RESPONSES 1 Introduction It is clear from the very small number of MAA approved to date that the registration process for ATMPs is complex and not easily satisfi Add to Reading List Source URL: ct.catapult.org.uk Download Document from Source Website File Size: 296,47 KB Share Document on Facebook

	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v8Wa - View Document
	Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical DocID: 1v7ko - View Document
	INDUSTRY ISSUES What Is a Biopharmaceutical? DocID: 1v72B - View Document
	Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell DocID: 1v5W2 - View Document
	TERMINOLOGY What is a Biopharmaceutical? DocID: 1v5mX - View Document